Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-768P (RNA, U6 small nuclear 768, pseudogene) is a pseudogene related to U6 snRNA genes. The U6 small nuclear RNA (snRNA) is a highly conserved, non-coding RNA that is a key component of the spliceosome complex, which is responsible for catalyzing the removal of introns from pre-mRNA in eukaryotic cells[1][3]. However, as a "pseudogene," RNU6-768P does not code for a functional RNA product and does not have known biological function, involvement in disease, drug interactions, or established use as a therapeutic target[6][4]. Pseudogenes such as RNU6-768P are typically genomic sequences similar to functional genes but are non-functional due to mutations or lack of regulatory elements, and are not considered protein- or RNA-coding targets in therapeutic development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 768, pseudogene (RNU6-768P).